The Team
Dr Alan Kwong Hing
Chairman and Founder
Dr. AL is the Founder of PBM Group of Companies, he graduated with a Doctor of Dental Surgery degree (with distinction) from the University of Western Ontario in Canada. He received the University Gold Medal and completed a concurrent master’s degree in Pathology. He received the prestigious pre–Doctoral IADR Hatton award for his research on MRI’s and odontoblasts. He is a Diplomate of the ICOI, Fellow of the International College of Dentists and International Academy for Dental-Facial Esthetics. He is an Occupational Therapist, has multiple degrees and has received numerous awards.
He has had a diverse career as a solo dental practitioner and owner of large multi-dental office groups in Canada, the UK and US called Clear Choice Dental Implant Centers. He has owned dental and specialized orthodontic laboratories, a dental models company, dental supply company as well a company that manufactured orthodontic wires and accessories.
He was a KOL for SteriOss and NobelBiocare for many years and worked with the team to develop the NobelBiocare Replace Implant. He ran a comprehensive dental mini residency to train dentists and their teams in dental implant surgery and restorative procedures.
His interest in the field of photobiomodulation began almost 20 years ago. As an implant surgeon he was looking for methods to help alleviate pain associated with dental implant surgery, speed up bone graft healing and decrease time for implant stability so teeth or dentures could be attached faster and increase function and esthetics for patients. In a serendipitous manner he and another dentist discovered using LED’s enhanced implant stability and bone graft healing and created a device that would achieve this function. Subsequently a device to decrease orthodontic treatment time and pain was also developed.
Dr Al formed PBM Healing International to continue developing dental, medical and wellness devices using Photobiomodulation as the primary energy source for humans and animals. There are many advantages of photobiomodulation including: NATURAL, FASTER TREATMENT, FASTER RECOVERY, DECREASED PAIN, DRUG FREE, CONVENIENT AND SAFE and SCIENTIFICALLY PROVEN with over 10,000 PUBLISHED STUDIES. As a result, Dr Al has committed to bringing these benefits to people by developing devices that can be applied for diverse areas including Brain Health and overall Body Wellness for people, their pets and horses.
He enjoys lecturing around the world most notably in the application of Photobiomodulation principles in the medical, dental, and animal devices that he has developed. He is a published author most notably for the “E Myth Dentist” with Michael Gerber and his E book Learn about Photobiomodulation.
He is the CEO of PBM Healing, a Founding Partner, Director, and Chief Executive Officer of Mandarin Capital Ltd, a Hong Kong-based asset Management and advisory Company specialising in start ups and growth stage technology companies.
Samuel began his career in 1999 as a research analyst for ING Barings in London before moving to ING Barings’ proprietary and market trading convertible bond desk. He was transferred to the Tokyo office in 2001 and, in 2003, joined Mizuho Securities in Hong Kong as Head of Asset Management. In this role, Samuel was tasked with setting up an internal hedge fund platform and managing two funds specializing in convertible bonds and volatility investments and additionally designed and implemented trading and operations infrastructures.
By the time Samuel left Mizuho Securities in 2010, he had held the title of Head of Asset Management and was registered Responsible Officer: Type 9. In 2011 Samuel briefly joined MF Global as Head of Derivatives with proprietary and client facilitation mandates. Before setting up Mandarin Capital Ltd in 2012, Sam held the position of Managing Director and Portfolio Manager at Richmond Asset Management.
Samuel Faveur
Chief Executive Officer
Dr Michael R Hamblin
Science and Research Advisor
Michael R Hamblin Ph.D. was a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School for 25 years, and is now a Distinguished Visiting Professor at the University of Johannesburg, South Africa and affiliated faculty at Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran.
He gained his PhD in organic chemistry from Nottingham Trent University in England. His research interests include photodynamic therapy, photobiomodulation, drug delivery, nanomedicine, and tissue engineering. His research program was supported by NIH, CDMRP, USAFOSR and CIMIT.
He has published over 750 peer-reviewed articles, over 150 conference proceedings, book chapters and International abstracts and holds 10 patents. He is Editor-in-Chief of “Photobiomodulation, Photomedicine and Laser Surgery”, Associate Editor for 10 journals, on the editorial board of a further 60 journals. He has an h-factor 148 and > 88,000 citations. He has authored/edited 36 textbooks on PDT, photomedicine, and nanomedicine including 13 SPIE proceedings.
Dr Hamblin was elected as a Fellow of SPIE in 2011, received the 1st Endre Mester Lifetime Achievement Award from NAALT in 2017, the Outstanding Career Award from the Dose Response Society, the 1st Ali Javan award for Photobiomodulation Basic Science Research from WALT in 2018, and the Lifetime Achievement Award from European Medical Laser Association in 2022.